Generic Name: Reeflec v
What is Reeflec V?
Dose modification for paediatric patientsDose reduction in paediatric patients without cardiac disease follows the same guidelines as adult patients without cardiac disease regarding haemoglobin levels Table 2. There are no data for paediatric patients with cardiac disease see section 4. Table 3 provides guidelines for discontinuation based on the patient's indirect bilirubin concentration. However, as in younger patients, renal function must be determined prior to administration of Rebetol see section 5.
Paediatric patients children 3 years of age and older and adolescents Rebetol may be used in combination with peginterferon alfa-2b or interferon alfa-2b see section 4. The selection of Rebetol formulation is based on individual characteristics of the patient.
The safety and efficacy of ribavirin used together with direct-acting-anti-virals in these patients has not been established. No data are available.
Long term hepatitis C infection can cause liver swelling that lead to serious liver conditions such as scarring, caner and organ failure. The medication can help control hepatitis C but is not a cure for the infection and cannot prevent the spreading of hepatitis C to others.
Adverse effects Patients using Rebetol may encounter unwanted side effects such as: Contact a doctor immediately should side effects persist or encounter more severe side effects such as:Warnings Immediately proceed to your nearest emergency department if you suffer an allergic reaction.
Symptoms usually associated with such a reaction include difficulty breathing or swallowing, chest tightness, swelling, skin rashes, and hives. Rebetol is not always suitable for all patients. This product is only for use as prescribed and instructed. Adverse effects Patients using Rebetol may encounter unwanted side effects such as: Nausea Diarrhea Upset stomach Headaches Dizziness Dry mouth Fatigue Low appetite Contact a doctor immediately should side effects persist or encounter more severe side effects such as: Vision problems Flu like symptoms Chest pain Shortness of breath Mental or mood changes Jaundice Easy bruising or bleeding Muscle pain or weakness Warnings Immediately proceed to your nearest emergency department if you suffer an allergic reaction.
Daher kann Rebetol gemeinsam mit diesen Substanzen an Patienten mit gleichzeitigen HIV- und Hepatitis-C-Virus HCV -Infektionen verabreicht werden. Weibliche Patienten: Rebetol darf nicht von schwangeren Frauen angewendet werden.
How should I take Reeflec V?
The study results are summarized in Table 7. Defined as HCV RNA below limit of detection using a research based RT-PCR assay at end of treatment and during follow-up period Long-term efficacy dataA five-year long-term, observational, follow-up study enrolled 94 paediatric chronic hepatitis C patients after treatment in a multicentre trial. Both ribavirin and its triazole, carboxamide and triazole carboxylic acid metabolites are also excreted renally.
Rebetol in combination with interferon alfa-2bMultiple-dose pharmacokinetic properties for Rebetol capsules and interferon alfa-2b in children and adolescents with chronic hepatitis C between 5 and 16 years of age are summarized in Table 8. Calibrations are marked at 0.
What should I avoid while taking Reeflec V?
Randomised trial of interferon alfa-2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alfa-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Davis GL, Estaban-Mur R, Rustgi V, Hoefs J, Gordon SS et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C.
Electrocare have been serving Northallerton and all surrounding towns and villages such as Bedale, Leyburn, Thirsk, Ripon, Catterick, Richmond, Darlington, Stockton-on-Tees, Middlesbrough and Ingleby Barwick to name a few. Rebetol non deve mai essere usato in monoterapia da soloma esclusivamente in associazione con un interferone un altro tipo di farmaco usato nel trattamento dell'epatite. Il trattamento con Rebetol deve essere avviato e monitorato da un medico esperto nella terapia dell'epatite C cronica.
La dose di Rebetol dipende dal peso corporeo del paziente e va da tre a sette capsule al giorno nei soggetti con peso corporeo superiore a 47 kg. Nei pazienti di peso inferiore, viene utilizzata la soluzione orale alla dose di 15 mg per chilogrammo di peso corporeo al giorno.
Reeflec V side effects
You should have an eye exam before you start treatment with REBETOL. Your health care provider should check your blood and heart before you start treatment with REBETOL. REBETOL may make your diabetes worse or harder to treat. It is not known if REBETOL passes into your breast milk. You and your health care provider should decide if you will take REBETOL or breastfeed.
If you cannot swallow REBETOL Capsules whole, tell your health care provider.
Common Reeflec V ide effects may include:
Sodium citrate Citric acid, anhydrous Sodium benzoateGlycerol SucroseSorbitol liquid crystallising Propylene glycolPurified WaterNatural and artificial bubble gum flavouring 3 yearsAfter first opening: the medicinal product should be used within one month.
Dosing of Rebetol for children and adolescent patients is determined by the patient body weight.
These doses in animals produce systemic exposures well below those achieved in humans at therapeutic doses.
If you miss a dose of COPEGUS, take the missed dose as soon as possible during the same day.
Rebetol nu trebuie utilizat niciodata in monoterapie, ci numai impreuna cu peginterferon alfa-2b sau interferon alfa-2b alte medicamente folosit in tratarea hepatitei. Rebetol se administreaza la pacienti care nu au fost tratati in in trecut, atat timp cat ficatul acestora inca functioneaza si virusul hepatitei C este prezent in sange. Acesti pacienti includ adulti cu varste de cel putin 18 ani care sufera de ciroza hepatica scleroza a ficatuluidar al caror ficat inca functioneaza si adulti care sunt, de asemenea, infectati cu virusul imunodeficientei umane hiv.
Where can I get more information?
What are the severe side effects of ribavirin.
Ribavirin will likely continue to play an important role in the treatment of hepatitis C, but eventually will likely be replaced by highly effective, better tolerated combinations of direct acting agents.